Pharma Stocks
-
Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Side…
Technical Trend Overview and Price Movement The pharmaceutical giant currently trades at ₹1,181.10, slightly down from the previous close of…
Read More » -
Jazz Pharma at TD Cowen and Barclays health events
DUBLIN, Feb. 17, 2026 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the…
Read More » -
Adial Pharma at Oppenheimer healthcare conference
Adial Pharmaceuticals (NASDAQ: ADIL) announced CEO Cary Claiborne will present at the Oppenheimer 36th Annual…
Read More » -
Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixe…
Open Interest and Volume Dynamics The latest data reveals that Aurobindo Pharma’s open interest (OI) in derivatives rose sharply from…
Read More » -
Strides Pharma Science Ltd Valuation Shifts to Very Attra…
Valuation Metrics Reflect Improved Price Attractiveness Strides Pharma’s recent valuation upgrade is underpinned by a P/E ratio of 14.34, which…
Read More » -
What to Expect From These Drug/Biotech Players This Earnings Season?
The fourth-quarter 2025 reporting season for the Medical sector is nearing its final stretch, with only a handful of pharma…
Read More » -
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off…
Read More » -
Torrent Pharma shares soar 6% to 52-week high post Q3 results, dividend declared; check numbers
Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL…
Read More » -
Weekly Market Recap: Nifty Outlook & Top Stocks
Nifty closed 0.87% lower last week as a tech sell-off and global cues dampened sentiment. While IT giants like Infosys…
Read More » -
Assessing Ligand Pharmaceuticals (LGND) Valuation After Recent Share Price Weakness And Strong 1 Year Return
Event context and recent stock performance Ligand Pharmaceuticals (LGND) has come into focus after a period in which its shares…
Read More »